December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

20.83 +0.81 (+4.05%)
Delayed Quote Updated: 3:10 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Fortrea Reports Third Quarter 2026 Results
Sustained commercial momentum, continued margin improvement, and targeted investments strengthen growth foundation 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea to Participate in Jefferies Global Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development
Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in Australia 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials
Expands Fortrea’s early clinical development network with dedicated bioanalytical capabilities, increased clinical research unit capacity and a more integrated platform for clients 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea to Participate in September Investor Conferences
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea’s early clinical development network as Worldwide advances its strategy to scale clinical development, therapeutic leadership... 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Reports Second Quarter 2026 Results
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Kaskela Law Firm Announces Investigation of Fortrea Holdings Inc. (FTRE) and Encourages Long-Term FTRE Shareholders with Investment Losses to Contact the Firm
From Kaskela Law LLC
Via Business Wire
News headline image
Fortrea Announces Date for Second Quarter 2026 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Names Jason Knoblauch as Chief Financial Officer
Jason Knoblauch will succeed Jill McConnell as chief financial officer of Fortrea 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea to Attend Jefferies Global Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Reports First Quarter 2026 Results
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
AI-enhanced suite of solutions features new and improved technology to empower efficiency, confidence and quality 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
Adds to executive focus on early clinical development and deepens medical and scientific partnership with clients 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Alexandria Real Estate Equities, Inc. (NYSE: ARE); CarMax, Inc. (NYSE: KMX); Fortrea Holdings, Inc. (NASDAQ: FTRE); StubHub Holdings, Inc. (NYSE: STUB): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims
From Grabar Law Office
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.